lithium has been researched along with Granulocytic Leukemia, Chronic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bincoletto, C; Calgarotto, AK; da Silva S Duarte, A; Palmeira-Dos-Santos, C; Peixoto-da-Silva, J; Pereira, GJS; Pericole, FV; Rocha, KR; Saad, STO; Smaili, SS | 1 |
1 other study(ies) available for lithium and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Lithium, a classic drug in psychiatry, improves nilotinib-mediated antileukemic effects.
Topics: Autophagy; Cell Death; Cell Survival; Clone Cells; Fusion Proteins, bcr-abl; Glycogen Synthase Kinase 3 beta; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lithium; Neoplastic Stem Cells; Phosphorylation; Pyrimidines | 2018 |